SCHEMBL2233338

SCHEMBL2233338

C=CCCC(=O)Nc1cc(NC(=O)OC)ccc1-c1ccnc(CCC=CNC(=O)OC(C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SREBF2 Q12772 1/20 0.40
AAK1 Q2M2I8 8/20 0.33
HDAC3 O15379 7/20 0.32
HDAC1 Q13547 6/20 0.32
HDAC2 Q92769 6/20 0.32
HDAC10 Q969S8 5/20 0.32
HDAC6 Q9UBN7 3/20 0.32
NCOR2 Q9Y618 1/20 0.32
NQO2 P16083 1/20 0.32
MTNR1A P48039 1/20 0.32
MTNR1B P49286 1/20 0.32
HDAC8 Q9BY41 5/20 0.31
CYP17A1 P05093 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
MAP4K4 O95819 1/20 0.30
SHMT1 P34896 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL616816 0.84 SREBF2 (0.38) SREBF2AAK1
SCHEMBL616050 0.83 SREBF2 (0.44) SREBF2AAK1CYP17A1MAP4K4
SCHEMBL2236912 0.83 SREBF2 (0.39) SREBF2AAK1CYP17A1
SCHEMBL616659 0.83 SREBF2 (0.38) SREBF2AAK1
SCHEMBL2234474 0.83 SREBF2 (0.38) SREBF2AAK1
SCHEMBL14691373 0.83 SREBF2 (0.45) SREBF2AAK1CYP17A1MAP4K4SHMT1
SCHEMBL2236917 0.82 SREBF2 (0.38) SREBF2AAK1
SCHEMBL615789 0.81 SREBF2 (0.38) SREBF2AAK1
SCHEMBL616966 0.80 SREBF2 (0.40) SREBF2AAK1MAP4K4
SCHEMBL615850 0.80 F11 (0.36) SREBF2AAK1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2534154-A1 MACROCYCLES AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2012-12-19 EP disclosed
WO-2011100401-A1 MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-08-18 WO disclosed